AstraZeneca (AZN) News Today $85.87 +0.38 (+0.44%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$86.72 +0.85 (+0.99%) As of 09:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AZN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period AstraZeneca succeeds in late-stage trial for blood pressure therapyOctober 7 at 11:00 AM | msn.comAstraZeneca (LSE:AZN): Exploring Valuation as Shares Move Steadily HigherOctober 7 at 11:00 AM | finance.yahoo.comAstraZeneca PLC $AZN Stock Holdings Lowered by Meitav Investment House Ltd.October 7 at 6:01 AM | marketbeat.comD.B. Root & Company LLC Cuts Stake in AstraZeneca PLC $AZNOctober 7 at 5:14 AM | marketbeat.comAstraZeneca's Baxdrostat meets main goal in high blood pressure studyOctober 7 at 2:14 AM | reuters.comAstraZeneca signs up to $555 million deal with US-based Algen to develop gene therapiesOctober 6 at 8:04 AM | reuters.comCullinan Associates Inc. Has $561,000 Position in AstraZeneca PLC $AZNOctober 6 at 5:48 AM | marketbeat.comValeo Financial Advisors LLC Raises Position in AstraZeneca PLC $AZNOctober 6 at 5:30 AM | marketbeat.comAstraZeneca inks $555 million gene-editing technology deal with Algen, FT reportsOctober 6 at 5:25 AM | reuters.comMarks Group Wealth Management Inc Sells 12,673 Shares of AstraZeneca PLC $AZNOctober 6 at 5:12 AM | marketbeat.comEmpirical Financial Services LLC d.b.a. Empirical Wealth Management Purchases 3,171 Shares of AstraZeneca PLC $AZNOctober 6 at 4:00 AM | marketbeat.comAstraZeneca's Datroway boosts survival in advanced breast cancer trialOctober 6 at 2:57 AM | reuters.comQRG Capital Management Inc. Has $15.02 Million Holdings in AstraZeneca PLC $AZNOctober 5 at 4:31 AM | marketbeat.comPure Financial Advisors LLC Buys New Position in AstraZeneca PLC $AZNOctober 5 at 3:40 AM | marketbeat.comAstraZeneca Announces Current Voting Rights and Share Capital StructureOctober 4, 2025 | theglobeandmail.comPenobscot Investment Management Company Inc. Acquires 10,267 Shares of AstraZeneca PLC $AZNOctober 4, 2025 | marketbeat.comFigure 8 Investment Strategies LLC Acquires New Shares in AstraZeneca PLC $AZNOctober 4, 2025 | marketbeat.comLGT Fund Management Co Ltd. Boosts Holdings in AstraZeneca PLC $AZNOctober 4, 2025 | marketbeat.comZWJ Investment Counsel Inc. Raises Stock Position in AstraZeneca PLC $AZNOctober 4, 2025 | marketbeat.comHilltop National Bank Invests $321,000 in AstraZeneca PLC $AZNOctober 4, 2025 | marketbeat.comAstraZeneca PLC $AZN Shares Bought by Mirae Asset Global Investments Co. Ltd.October 4, 2025 | marketbeat.comPublic Employees Retirement System of Ohio Takes Position in AstraZeneca PLC $AZNOctober 4, 2025 | marketbeat.comHardman Johnston Global Advisors LLC Trims Stock Position in AstraZeneca PLC $AZNOctober 3, 2025 | marketbeat.comCornell Pochily Investment Advisors Inc. Makes New Investment in AstraZeneca PLC $AZNOctober 3, 2025 | marketbeat.comHB Wealth Management LLC Sells 18,913 Shares of AstraZeneca PLC $AZNOctober 3, 2025 | marketbeat.comJanney Montgomery Scott LLC Purchases 7,496 Shares of AstraZeneca PLC $AZNOctober 3, 2025 | marketbeat.comTruist Financial Corp Buys 108,262 Shares of AstraZeneca PLC $AZNOctober 2, 2025 | marketbeat.comStock Traders Purchase High Volume of Call Options on AstraZeneca (NASDAQ:AZN)October 2, 2025 | americanbankingnews.comAstraZeneca (NASDAQ:AZN) Shares Gap Up - Should You Buy?October 1, 2025 | marketbeat.comAstraZeneca Target of Unusually Large Options Trading (NASDAQ:AZN)October 1, 2025 | marketbeat.comAstraZeneca shares leap with FDA set to review drug to treat breast cancerOctober 1, 2025 | marketwatch.comCNBC's UK Exchange newsletter: AstraZeneca gets a shot on Wall StreetOctober 1, 2025 | cnbc.comAstraZeneca's US listing may pull other firms from London in its wakeSeptember 30, 2025 | reuters.com26,567 Shares in AstraZeneca PLC $AZN Bought by Robbins FarleySeptember 30, 2025 | marketbeat.comAstraZeneca PLC $AZN Stock Position Lowered by Oak Family Advisors LLCSeptember 30, 2025 | marketbeat.comTrending tickers: Alibaba, AstraZeneca, GSK, Stellantis and GenmabSeptember 29, 2025 | msn.comAstraZeneca to List Shares Directly on New York Stock ExchangeSeptember 29, 2025 | msn.comAstraZeneca to list directly on NYSE while keeping U.K. listing; shares upSeptember 29, 2025 | finance.yahoo.comAstraZeneca to Adopt Direct U.S. Listing While Retaining London BaseSeptember 29, 2025 | msn.comAstraZeneca to directly list shares in New York, retain UK listingSeptember 29, 2025 | reuters.comDakota Wealth Management Reduces Stock Position in AstraZeneca PLC $AZNSeptember 28, 2025 | marketbeat.com3 Magnificent Stocks Under $100 to Buy Right NowSeptember 27, 2025 | fool.comFirst American Bank Has $1.46 Million Position in AstraZeneca PLC $AZNSeptember 27, 2025 | marketbeat.comCove Private Wealth LLC Buys Shares of 4,000 AstraZeneca PLC $AZNSeptember 27, 2025 | marketbeat.comMagnus Financial Group LLC Buys New Shares in AstraZeneca PLC $AZNSeptember 27, 2025 | marketbeat.comAstraZeneca (AZN) Stock Target Raised as Goldman Sachs Sees $3.7 Billion Drug PotentialSeptember 27, 2025 | msn.comAstraZeneca becomes latest drugmaker to launch direct-to-consumer platformSeptember 26, 2025 | msn.comYour AstraZeneca Medicine Could Be Cheaper As Much As 70%September 26, 2025 | benzinga.comBig Pharma braces for the next price cutSeptember 26, 2025 | proactiveinvestors.comAstraZeneca to Offer Discounted Drugs As Trump Pressures Pharma Industry to Cut PricesSeptember 26, 2025 | wsj.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼1.200.55▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼3225▲AZN Articles Average Week Get the Latest News and Ratings for AZN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for AstraZeneca and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Novartis News Novo Nordisk A/S News Sanofi News GSK News argenex News Takeda Pharmaceutical News BeOne Medicines News Insmed News BioNTech News Teva Pharmaceutical Industries News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
